Last reviewed · How we verify

NCT06227351

Completely Versus Partially Guided Zygomatic Implant

Completed NA Last updated 27 September 2024
What this trial tests

NA trial testing completely limiting computer generated surgical three-dimensional guide in Maxillary Deficiency in 6 participants. Completed in 25 September 2024.

Timeline
5 February 2024
Primary endpoint
25 September 2024
25 September 2024

Quick facts

Lead sponsorFayoum University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment6
Start date5 February 2024
Primary completion25 September 2024
Estimated completion25 September 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Fayoum University

Who can join

18 and older, any sex, with Maxillary Deficiency or Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of study is evaluation of accuracy of completely versus partially limiting computer generated surgical three-dimensional guides during placement of zygoma implants in patients with atrophic maxillae.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Accuracy of Zygomatic Implant Placement Using Completely Versus Partially Guided.
    Ghallab MK, Shabaan AA, Al-Mahalawy H, Taha M. · · 2026 · PMID 42087122 · DOI 10.1186/s12903-026-08436-x

Verify or expand the search:

Other Fayoum University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06227351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing